SI1014987T1 - Oral compositions of levosimendan - Google Patents

Oral compositions of levosimendan

Info

Publication number
SI1014987T1
SI1014987T1 SI9830645T SI9830645T SI1014987T1 SI 1014987 T1 SI1014987 T1 SI 1014987T1 SI 9830645 T SI9830645 T SI 9830645T SI 9830645 T SI9830645 T SI 9830645T SI 1014987 T1 SI1014987 T1 SI 1014987T1
Authority
SI
Slovenia
Prior art keywords
levosimendan
oral compositions
oral
compositions
Prior art date
Application number
SI9830645T
Other languages
English (en)
Slovenian (sl)
Inventor
Maarit Harjula
Ilkka Larma
Saila Antila
Lasse Lehtonen
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of SI1014987T1 publication Critical patent/SI1014987T1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9830645T 1997-09-26 1998-09-24 Oral compositions of levosimendan SI1014987T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI973804A FI973804A (fi) 1997-09-26 1997-09-26 Levosimendaanin oraalisia koostumuksia
PCT/FI1998/000753 WO1999016443A1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan
EP98946480A EP1014987B1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan

Publications (1)

Publication Number Publication Date
SI1014987T1 true SI1014987T1 (en) 2004-08-31

Family

ID=8549609

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830645T SI1014987T1 (en) 1997-09-26 1998-09-24 Oral compositions of levosimendan

Country Status (36)

Country Link
US (1) US6355269B1 (zh)
EP (1) EP1014987B1 (zh)
JP (1) JP4493840B2 (zh)
KR (1) KR100762022B1 (zh)
CN (1) CN1149994C (zh)
AR (1) AR013519A1 (zh)
AT (1) ATE260659T1 (zh)
AU (1) AU732489B2 (zh)
BG (1) BG64746B1 (zh)
BR (1) BR9813213A (zh)
CA (1) CA2304702C (zh)
CZ (1) CZ294984B6 (zh)
DE (1) DE69822172T2 (zh)
DK (1) DK1014987T3 (zh)
EA (1) EA001647B1 (zh)
EE (1) EE03854B1 (zh)
ES (1) ES2217580T3 (zh)
FI (1) FI973804A (zh)
GE (1) GEP20032943B (zh)
HK (1) HK1032001A1 (zh)
HR (1) HRP20000171B1 (zh)
HU (1) HUP0003757A3 (zh)
ID (1) ID24486A (zh)
IL (1) IL134802A (zh)
MX (1) MXPA00002956A (zh)
MY (1) MY118156A (zh)
NO (1) NO320047B1 (zh)
NZ (1) NZ503207A (zh)
PL (1) PL190862B1 (zh)
PT (1) PT1014987E (zh)
RS (1) RS49708B (zh)
SI (1) SI1014987T1 (zh)
SK (1) SK283187B6 (zh)
TR (1) TR200000635T2 (zh)
WO (1) WO1999016443A1 (zh)
YU (1) YU17700A (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9606474D0 (en) * 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
FI980901A (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI980902A (fi) 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaanin stabiileja koostumuksia
FI20000577A0 (fi) * 2000-03-13 2000-03-13 Orion Yhtymae Oy Pyridatsinyylifenyylihydratsoneja
DK1347747T3 (da) * 2000-12-22 2006-04-10 Baxter Int Fremgangsmåde til behandling af submikropartikelsuspensioner af farmaceutiske midler
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
FI20011465A0 (fi) * 2001-07-04 2001-07-04 Orion Corp Pyridatsinonijohdannaisen uusi käyttö
IL160570A0 (en) 2001-09-26 2004-07-25 Baxter Int Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
NZ597556A (en) 2009-07-14 2013-03-28 Cipla Ltd Process for preparing levosimendan and intermediates for use in the process
CN104418810A (zh) * 2013-09-04 2015-03-18 北京博时安泰科技发展有限公司 一种左西孟旦的合成新路线
CN103554032A (zh) * 2013-11-12 2014-02-05 江苏正大清江制药有限公司 高光学纯度(-)-6-(4-氨基苯基)-4,5-二氢-5-甲基-3(2h)-哒嗪酮的制备方法
ITMI20132185A1 (it) * 2013-12-23 2015-06-24 Edmond Pharma Srl Polimorfi di levosimendan
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
CN111474289A (zh) * 2019-10-31 2020-07-31 武汉嘉诺康医药技术有限公司 一种利用反相色谱分离分析左西孟旦中右西孟旦的方法
AU2020408323A1 (en) 2019-12-16 2022-08-11 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HF-pEF)
CN111548310B (zh) * 2020-05-12 2021-07-02 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型及其制备方法
CN111718299B (zh) * 2020-07-23 2023-03-10 成都欣捷高新技术开发股份有限公司 一种左西孟旦钠晶型b及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
GB9606474D0 (en) 1996-03-27 1996-06-05 Orion Yhytmo Oy Method for obtaining pure enantiomers of a pyridazinone derivative
GB9614098D0 (en) * 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
IL134802A0 (en) 2001-04-30
SK283187B6 (sk) 2003-03-04
AR013519A1 (es) 2000-12-27
EP1014987B1 (en) 2004-03-03
JP2001517702A (ja) 2001-10-09
HK1032001A1 (en) 2001-07-06
AU732489B2 (en) 2001-04-26
CZ2000919A3 (cs) 2000-09-13
CN1149994C (zh) 2004-05-19
ID24486A (id) 2000-07-20
HRP20000171A2 (en) 2000-12-31
FI973804A (fi) 1999-03-27
NO20001585L (no) 2000-03-27
HUP0003757A3 (en) 2001-07-30
PL190862B1 (pl) 2006-02-28
BR9813213A (pt) 2000-08-29
NO20001585D0 (no) 2000-03-27
FI973804A0 (fi) 1997-09-26
DK1014987T3 (da) 2004-05-24
BG64746B1 (bg) 2006-02-28
ES2217580T3 (es) 2004-11-01
NZ503207A (en) 2001-04-27
MXPA00002956A (es) 2003-05-19
TR200000635T2 (tr) 2000-09-21
HUP0003757A2 (hu) 2001-05-28
CN1271282A (zh) 2000-10-25
IL134802A (en) 2004-01-04
EA200000360A1 (ru) 2000-10-30
RS49708B (sr) 2007-12-31
CA2304702C (en) 2007-09-04
CZ294984B6 (cs) 2005-04-13
JP4493840B2 (ja) 2010-06-30
DE69822172T2 (de) 2005-02-24
EE200000187A (et) 2001-04-16
HRP20000171B1 (en) 2009-06-30
EP1014987A1 (en) 2000-07-05
EE03854B1 (et) 2002-10-15
BG104250A (en) 2000-12-29
SK3842000A3 (en) 2000-09-12
GEP20032943B (en) 2003-04-25
YU17700A (sh) 2002-10-18
KR20010030679A (ko) 2001-04-16
NO320047B1 (no) 2005-10-17
PT1014987E (pt) 2004-06-30
CA2304702A1 (en) 1999-04-08
US6355269B1 (en) 2002-03-12
DE69822172D1 (de) 2004-04-08
WO1999016443A1 (en) 1999-04-08
AU9350698A (en) 1999-04-23
ATE260659T1 (de) 2004-03-15
MY118156A (en) 2004-09-30
KR100762022B1 (ko) 2007-09-28
EA001647B1 (ru) 2001-06-25
PL339461A1 (en) 2000-12-18

Similar Documents

Publication Publication Date Title
HK1017854A1 (en) Oral composition
EP1072253A4 (en) PREPARATIONS TO BE ORALED
ZA9810217B (en) New composition of matter
PL322136A1 (en) Oral compositions
EP1020193A4 (en) ORAL PREPARATION
IL134802A0 (en) Oral compositions of levosimendan
HUP0002216A2 (en) Oral compositions
ZA984127B (en) New composition of matter
GB9513694D0 (en) Oral compositions
GB9715972D0 (en) Oral compositions
GB9425934D0 (en) Oral compositions
PL338922A1 (en) Oral compositions
GB9515597D0 (en) Oral compositions
ZA955519B (en) Oral compositions
PL320866A1 (en) Oral compositions
HUP0100452A3 (en) Transmucosal formulations of levosimendan
PL321282A1 (en) Oral compositions
HUP9801706A3 (en) Oral compositions
GB9425933D0 (en) Oral compositions
GB9618964D0 (en) Oral composition
ZA981305B (en) Denture cleansing composition
GB9713403D0 (en) Microtextured oral hygiene compositions
SG63838A1 (en) Oral composition
GB9705844D0 (en) Oral prophyllactic compositions
GB9712029D0 (en) New compositions of matter